Directory · DE
Biotechnology in Germany
A register of firms and the professionals working at them in the Biotechnology sector based in Germany. Browse the public index, then filter or export on Kipplo.
Companies
237 on file
Knauer
We separate molecules and unite people. We are the largest liquid chromatography focused company in the world! We support scientists with analysis and purification of their products. Our customers work in the food safety, chemical and pharmaceutical industries. We believe in science! That's why we support universities worldwide to reach a higher level of education. Our clear focus allows us to offer solutions that only KNAUER can provide. think LC. think KNAUER. Based in Berlin, KNAUER is a medium-sized, owner-managed company that has been serving the sciences since 1962. We develop and manufacture scientific instruments of superior quality for liquid chromatography, including: • Analytical HPLC / UHPLC • Preparative HPLC • Fast protein liquid chromatography (FPLC) • Multi-column chromatography / Simulated moving bed (SMB) chromatography • Lipid nanoparticle formulation units for R&D and production scale High pressure dosing, in-line detection systems, and osmometry are additional business areas. With 180 employees, we are an established manufacturer of HPLC systems and components. Our valves, pumps, detectors, and other components are used for many separation processes outside of HPLC and are popular with customers who want custom solutions (OEM). KNAUER is an ideal partner for those who want more than standard solutions can provide. Osmometers for the determination of molality were the first products of the family business and the cornerstone of its success. KNAUER continues to develop and manufacture state-of-the-art osmometers. Furthermore, the KNAUER Academy offers courses on HPLC and application development. We support technological advancement today and in the future.
51 to 200 staff
Biontech Imfs
BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also
201 to 500 staff
C-Lecta Gmbh
c-LEcta is a global biotechnology company with over 20 years experience in the development, production and distribution of enzyme products. World-class enzyme engineering and production technologies are used to provide the food, feed, beverage and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. Since 2022 c-LEcta is part of the Kerry Group and is operator of the recently opened Kerry Biotechnology Centre. The Kerry Biotechnology Centre brings together the full biotechnology journey – from enzyme discovery and strain engineering to process development and production – all under one roof. 80+ scientists and innovation experts are focused on driving the discovery of next-generation solutions. Imprint: Privacy Policy:
51 to 200 staff
Bilacon
Willkommen bei bilacon -Ihrem Partner für Lebensmittelanalytik und Labordienstleistungen in Berlin Sie benötigen Unterstützung in der Qualitätskontrolle und bei Hygienefragen während der Herstellung von Lebensmitteln, Futtermitteln, Kosmetika oder Tabak? Dann sind wir bei bilacon Ihr zuverlässiger und durch Gegenprobensachverständige amtlich autorisierter Partner für alle Belange von der Rohware bis zum fertigen Endprodukt. Mit einer mehr als 30-jährigen Expertise und unserem umfangreichen, akkreditierten Analysespektrum unterstützen wir Sie in allen Fragen rund um die Sicherheit Ihrer Produkte.
201 to 500 staff
Ethris
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners.
51 to 200 staff
Oncimmune - An Alden Scientific Company
Oncimmune has developed the most advanced and comprehensive analytical platform for the discovery of Antibody / Autoantibody Biomarker Signatures. ImmunoINSIGHTS™, the best-in-class biomarker discovery engine, provides access to the B cell repertoire and a pivotal class of biomarkers. With one of the world’s largest antigen libraries covering human antigens and multi-species variants, we profile antibodies from various biologic samples in very low volume (50 µl). Developed and curated by immunologists and a team of bioinformaticians, we offer high content biological insights and analytics powered by proprietary machine learning algorithms, models and deep knowledge mining solutions. Our platform uses Luminex xMAP® – the world’s most used multiplexing technology. At Oncimmune, our mission is to develop innovative technologies and solutions to improve the understanding of the immune system leading to more effective, targeted and safer treatments and better diagnosis. Our scientists work hand-in-hand with our clients to discover relevant and insightful biomarkers.
11 to 50 staff
Biozol Gmbh
Seit 1989 ist BIOZOL Ihr Vertriebs- und Servicepartner für Produkte und Dienstleistungen im Bereich der Biowissenschaften und Diagnostik. Wir bieten Ihnen mehr als 22 Millionen Produkte von mehr als 180 Partnerfirmen weltweit. Für unsere Kunden überwinden wir nationale Grenzen, Zoll- und Einfuhrbestimmungen. So erhalten Sie für Ihre Forschung das perfekte Produkt, wo auch immer es hergestellt wird. Diesen Service bieten wir Ihnen für alle Hersteller weltweit, auch wenn diese keine offiziellen Partner von BIOZOL sind. So sind Sie nur einen Mausklick von Ihren gewünschten Life-Science-Produkten entfernt. Dieser Service wird durch unser Kundenbetreuungsteam aus Wissenschaftlern mit langjähriger Erfahrung in der Forschung vervollständigt. Mehr als zufriedene Kunden aus Universitäten, Forschungsinstituten sowie Unternehmen der Pharma- und Biotech-Industrie profitieren seit 30 Jahren von unseren Dienstleistungen. Schnelle Reaktionszeiten, direkter Support und persönlicher Kundenkontakt haben bei uns Priorität. Auf einen Blick - Ihre Vorteile bei BIOZOL: Alles aus einer Hand Bei uns erhalten Sie über 20 Millionen Produkte von über 180 ausgewählten Herstellern weltweit. 100% Zufriedenheitsgarantie Unsere Produkte sind von höchster Qualität – und wir erst zufrieden, wenn Sie es auch sind. 30 Jahre Erfahrung Schon seit 1989 beliefern wir Universitäten, Großforschungseinrichtungen und Firmen. Wir kommen aus der Wissenschaft Unser Kundendienst besteht aus studierten Naturwissenschaftlern mit Forschungserfahrung. Produktsuch-Service Sie suchen ein bestimmtes Produkt – unser wissenschaftlicher Kundendienst findet es für Sie. Globale Beschaffung Sie suchen ein Reagenz, das unsere Herstellerfirmen nicht anbieten – auch das finden wir für Sie. Einfaches Einkaufsystem Unkomplizierte Bestellung – schnelle Lieferung – lokaler Ansprechpartner – transparente Preise. Scientific Content Bitte besuchen Sie unseren Scientific Content Bereich für mehr Informationen
51 to 200 staff
Molzym Gmbh & Co. Kg
Molzym is a developer and manufacturer of innovative products for molecular microbiology and microbial pathogen diagnostics. Products range from pre-analytical kits for the enrichment and extraction of microbial DNA to analytical PCR kits with ultra-clean DNA-free reagents and are distributed in more than 30 countries worldwide. MolYsis™ is Molzym’s proprietary technology of human DNA removal and targeted isolation of microbial DNA from a variety of liquid and tissue samples including whole blood, CSF, BAL, joint aspirates, tissue biopsies, abscesses and other materials. Molzym’s ultra-clean PCR and real-time PCR assays, targeting the 16S/18S genes, allow detection, even at low amounts, and identification down to species level with subsequent sequencing. In addition, Molzym offers CE IVD-marked solutions for the culture-independent detection of pathogens in clinical diagnostics. Manual DNA isolation can be accomplished with SepsiTest™-UMD and with Micro-Dx™ the process is performed fully automated on the SelectNA™plus instrument. It combines highest technical advances with demands for contamination-free and low-hands-on processing of samples. This together with the extremely active broad-range PCR or Real-Time PCR followed by sequencing analysis enables the sensitive detection and identification of pathogens. Learn more about microbial enrichment, manual and automated solutions, molecular diagnostics and NGS and get an inside view on Molzym - read our blog at
11 to 50 staff
Sitools Biotech Gmbh
We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design algorithms, and quality production to achieve highly precise and rapid results. siTOOL’s reagents are used by Pharma for target discovery and validation and are mentioned in a growing list of academic publications. Comprised entirely of scientists, siTOOLs provides outstanding technical support and offers bespoke experimental and bioinformatic services, making it a favoured research partner for accelerating scientific discoveries and drug development.
1 to 10 staff
Zyagnum Ag
We are convinced that early detection of diseases is the prerequisite for better treatment options and thus optimal chances of recovery. That is why we are driven by the vision of making chronic health imbalances diagnosable even before the disease can manifest itself. This is the prerequisite for turning the early detection of life-changing diseases such as cancer, Alzheimer’s or diabetes into true prevention. Our aim is to make our diagnostics as simple, cost-effective, and burden-free as possible so that as many people as possible can benefit from them. Imprint: Privacy Policy: https://bit.ly/3d1YHzO
51 to 200 staff
Biomol Gmbh
In 1968, the moon was discovered as a travel destination and revolution was recognized not as a result of hardship and misery but of dissatisfaction with circumstances. Also in tranquil Ilvesheim, close to Heidelberg, visions of the future were conceived. Ewald Barth discovered the world of quality reagents as a commodity for research and as a source for launching BIOMOL. It has been more than 55 years since: The moon is today once more beheld rather at long range and revolutions are in Germany plotted by locomotive drivers. Today,"biotech" is an established term. While IT business has lived through a crash, the world of researchers and reagents is steadily advancing at an amazing pace. Apart from regular changes, the growing dynamics of this economic branch are also being felt in Hamburg. Companies are being taken over, join forces, new companies emerge, and globalization is not a catchword but daily routine. In Hamburg, nontheless, Biomol remains grounded. There is no need of a crystal palace as a signal of growth: The company has move to larger offices in 2018, the sales team is being extended, and the sales platform for the by now more than products is being brought up to global standards via inter- and intranet. Apart from that, we do what we have always done: a good job. Thus, in the long run, evolution has an edge over revolution. This does not mean we disregard revolution. Revolution creates the novel and we look for the novel. But revolutions lack steadiness, which is also key to us - for at least another 55 years.
11 to 50 staff
Corden Biochem
The Corden BioChem Group is a leading contract development and manufacturing organization (CDMO) for biotechnological products. Our facilities in Germany and Romania provide customers with a comprehensive upscaling pipeline: from lab-scale prototyping in Berlin, through scale-up and commercial scale fermentation and downstream processing in Frankfurt, to bulk production of up to 2,500 m3 in Podari, Romania. Together we offer the largest fermentation and downstream processing capacities in Europe. Our facility in Podari, Romania, will become operational in 2026. We operate across diverse fields, including food and feed products, technical applications, functional ingredients, and fine chemicals.
51 to 200 staff
Proteinea
Proteinea is a pioneering TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. Our mission is to accelerate the development of life-saving therapies, pushing the boundaries of science and technology to improve patient outcomes.
11 to 50 staff
Avencell
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
51 to 200 staff
Biocat Gmbh Part Of Addlife
With over 25 years of experience, BioCat GmbH is a trusted provider of high-quality research reagents, instruments and advanced technologies in the fields of genomics, proteomics and cell biology. Founded in and headquartered in Heidelberg, Germany, BioCat specializes in delivering innovative tools that empower life science research across academic institutions, biotechnology companies and the pharmaceutical industry. Our mission is to enhance scientific discovery by offering reliable, state-of-the-art solutions that accelerate progress in biomedical research. BioCat has consistently expanded its comprehensive portfolio of products manufactured by a network of world-wide suppliers to include some of the recent developments available in life sciences. The company operates from the Heidelberg Technology Park, near the German Cancer Research Center, allowing it to stay closely connected to leading scientific research. As a dedicated partner to the research community, BioCat provides scientists with cutting-edge tools and personalized customer support to help streamline workflows and maximize research outcomes. Our experienced team works closely with researchers to ensure the most effective use of our products, while strong, long-standing relationships with our suppliers enable us to adapt quickly to new scientific and technological trends. BioCat’s broad product offering and responsive customer service make us a preferred partner for laboratories seeking reliable research solutions. At BioCat, we believe in continuous progress and are striving to complement our product range with novel technologies that meet the evolving needs of the life science community. If you are looking for a capable and experienced partner to distribute your products within the German and European research markets, we welcome the opportunity to collaborate. Please contact us.
11 to 50 staff
Bitop Ag - The Ectoin Company
We are The Ectoin® Company. bitop has discovered and unleashed the power of Ectoin® 30 years ago, collaborated with the most renowned scientists to discover its secrets and invested everything into the biotechnological production of the purest and safest Ectoin®. This is why we are the world leader in Ectoin® production and have the only Ectoin® in medical grade: medEctoin®. Medical devices, cosmetics, animal health products, life sciences - this is where you will find this marvelous molecule. And chances are pretty high that it has been produced by us. bitop is Ectoin®. And Ectoin® is bitop. By the way, have you already been introduced to Glycoin®?
51 to 200 staff
Cellbricks Therapeutics
Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale. For inquiries please contact: mm@cellbricks.com
11 to 50 staff
Interherence
Our state-of-the-art devices target the optical microscopy market worldwide with a focus on high and super-resolution applications.#QuScite is the first commercial implementation of waveguide-based TIRF microscopy. https://interherence.com/quscite/#VAHEAT is a miniaturized temperature controller for microscopy. https://interherence.com/vaheat/ Ease of use and increased experimental reproducibility is what we aim for when designing our products. We are open to custom solutions and OEM partnerships!
11 to 50 staff
Sciomics
Protein profiling plays a crucial role in the advancement of biomedical research, enabling us to improve patients' quality of life by utilizing molecular signatures for accurate diagnosis and treatment. At Sciomics, our passion for advanced protein profiling is driving the future of Precision Medicine. We are continually expanding our biomarker signature pipeline to address a wide range of clinical indications and to advance Precision Diagnostics. Our cutting-edge services enable scientists worldwide to unravel the complexities of disease, uncover modes of action and identify promising protein biomarker candidates. Our service portfolio is anchored in our state-of-the-art scioDiscover microarray platform for protein and post-translational modification profiling. We are proud to support a wide range of research, from basic scientific discovery to breakthrough pharmaceutical initiatives (R&D). scioDiscover is a high-content, high-throughput system that provides a fast and cost-effective solution to your research needs. Its results are seamlessly translated into validation and clinical assays, enabling breakthrough biomarker discovery and preclinical drug development. Our team is dedicated to supporting you throughout your project: Project Planning: From planning to execution, we will help you navigate the most efficient route to achieve your research objectives. Technical Expertise: Our team provides unmatched proficiency in your proteomic analysis endeavors. Customized Solutions: We provide customized solutions to meet your specific research needs. Comprehensive Study Report: Our services include a comprehensive data analysis and a customized report. Our Platform Is Used For: • Protein Biomarker Identification and Verification • Novel Drug Target Discovery • Mode-of-Action Analysis • Pathway Activity Analysis • Disease Model Characterization, among other key applications Join us on our mission to revolutionize medicine!#PrecisionMedicine #Proteomics
11 to 50 staff
Sensid Gmbh
SensID is specialized in the design and manufacturing of Reference Material for DNA diagnostic procedures. Our reference material is manufactured under the highest standards in the world. The products are especially designed and suitable for R&D, Validation, external control, preparation of accreditation processes, round robin tests, as part of your diagnostic device or kit and whatever you can imagine. We provide: gDNA, cfDNA/ctDNA, cfDNA/ctDNA in Plasma, FFPE tissue and slides with defined allelic frequency and 100% defined sequence, defined mixing ratio of wt/mut cells and more for use in PCR, Sequencing, or any application you can imagine. For further information, please contact us under: info@sens-id.com
11 to 50 staff
Vitrocell Systems Gmbh
VITROCELL® is specialized in the development of advanced equipment solutions for in vitro characterization of airborne substances such as gases, complex mixtures, nanoparticles and fibers at the air/liquid interface. The VITROCELL® Skin range offers high-tech equipment solutions for the exposure of skin tissue to solid, pasty, liquid or gaseous substances - a powerful alternative to glass-made Franz cells offering improved handling, higher throughput and options for automation. Our integral commitment to your research means you can count on us to propose optimally tailored components, provide turnkey installations, international training and a world-class service exactly to your requirements.
11 to 50 staff
Ahn Biotechnologie Gmbh
AHN Biotechnologie GmbH, a German manufacturer, excels in manufacturing high-quality laboratory products. Our expertise spans Life Sciences consumables, liquid handling instruments, benchtop lab equipment, and consumables for DNA/RNA purification. We proudly market our products globally under the CAPP, AHN, and Maxxline brands. Additionally, AHN Biotechnologie GmbH is a trusted partner for private label and OEM manufacturing, catering to leading companies in our industry.
51 to 200 staff
Brain Biotech Ag
The BRAIN Biotech Group is a leading company in the research, development and production of specialist enzymes with a focus on the food and life science industries. In addition, the Group develops microbial production organisms and scalable bioprocesses for the economic production of specialty enzymes and other proteins. Customized innovative biological solutions for more sustainable products and processes round off the portfolio. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The business activities of the integrated company are divided into the two segments BRAINBiocatalysts (development, production and distribution of specialty enzymes, microorganisms, ingredients) and BRAINBioIncubator (research-intensive development projects, pharmaceuticals). For production, the Group operates fermentation plants in the UK as well as production facilities in continental Europe and the USA. BRAIN Biotech AG - Privacy Policy: https://t1p.de/id1rg Imprint: https://t1p.de/glka
201 to 500 staff
Fraunhofer Izi-Bb
Pressemitteilung: TruContact® - Reaktive Beschichtung für 2023/2024 veröffentlicht** E-Paper: https://s.fhg.de/IZI-BB-JB Erfahren Sie mehr zu unserer Vision für die Zukunft des Instituts und über spannende Innovationen und neue Partnerschaften im neuen Jahresbericht 2023/2024. Der Institutsteil Bioanalytik und Bioprozesse IZI-BB adressiert mit seinen Kompetenzen in Analytik, Diagnostik, Biosystemtechnik und biologische Sicherheit zukunftsträchtige und nachhaltige Entwicklungsfelder. Mit den Schwerpunkten Biosensoren, Lab-on-a-Chip-Technologien, Miniaturisierung von biologischen Prozessen und Nanomaterialien sehen wir große Chancen im Bereich der digitalen Diagnostik und neue Möglichkeiten für die Gesundheitsversorgung. Wir sind fest entschlossen, innovative Lösungen zu entwickeln, die einen realen gesellschaftlichen Nutzen bieten, insbesondere in benachteiligten Regionen.
51 to 200 staff
